CRISPR for gene editing in neuroscience and neurological disease
Publisher
Whitehouse Publishing
Reference21 articles.
1. Cong L, Ran FA, Cox D, et al. Multiplex genome engineering using CRISPR/Cas systems. Science 2013;339:819-23. doi:10.1126/science.1231143.
2. Sander JD, Joung JK. CRISPR-Cas systems for editing, regulating and targeting genomes. Nat Biotechnol 2014;32:347-55. doi:10.1038/nbt.2842.
3. 3. Ran FA, Hsu PD, Wright J, et al. Genome engineering using the CRISPR-Cas9 system. Nat Protoc 2013;8:2281-308. doi:10.1038/nprot.2013.143.
4. Dominguez AA, Lim WA, Qi LS. Beyond editing: repurposing CRISPR-Cas9 for precision genome regulation and interrogation. Nat Rev Mol Cell Biol 2015;17:5-15. doi:10.1038/nrm.2015.2.
5. Russo FB, Cugola FR, Fernandes IR, et al. Induced pluripotent stem cells for modeling neurological disorders. World J Trasnplant 2015;5:209-21. doi:10.1002/biot.201400010